Maziere et al.: Effects of suloctidil oh lipid metabolism in cultured human fibroblasts J. Clin. Chem. Clin. Biochem. Vol. 26, 1988, pp. 3-6 © 1988 Summary: Human foetal lung fibroblasts were pretreated for 24 h with the antithrombotic drug, suloctidil (1 to 10μπιο1/1), which induced a dose-dependent increase in LDL binding, uptake and degradation. At 10 μηαοΐ/ΐ suloctidil, the respective increases in these parameters were 40%, 80% and 50%. The same treatment also resulted in increases of 1.5 to 2-fold in the synthesis of sterols, fatty acids and triacylglycerols from sodium acetate. In contrast, the esterification of cholesterol with oleic acid was specifically decreased by 35% by 24 h pretreatment of fibroblasts with 10 μπιοΙ/1 suloctidil. A similar decrease of cholesterol esterification was observed in cholesterol-laden fibroblasts. It is suggested that these effects of suloctidil on LDL processing and cholesterol metabolism are related to the amphiphilic characteristics of the drug and to its calciumblocking properties.
Introduction
After binding to receptors, LDL uptake and degradation by cultured fibroblasts result in repression of endogenous cholesterol synthesis and stimulation of cholesterol esterification (1, 2) . The importance of this pathway arises from the fact that a decrease in LDL receptor number, as observed in familial hypercholesterolaeinia (3, 4) , leads to premature atherosclerosis. Besides the hormonal control of this pathway by insulin (5) or epinephrine (6) , it has been demonstrated that some amphiphilic drugs, such as phenothiazines (7), propranolol (8) , or AY 9944 (9, 10) , stimulate the LDL receptor pathway. This effect is probably mediated by a direct action of the drugs on the phosphplipid bilayer.
Suloctidil (1 -(4-isopropylthiophenyl>2^-octylaminopropanol) was originally used as an antispasmodic agent for the treatment of cerebral and peripheral artery insufficiencies (11, 12) . Subsequently, it was observed that this drug also inhibits platelet aggregation (13, 14) and prevents experimentally induced >) Laboratoires SEARLE, Departement Medical. thrombosis (15, 16) . It was also demonstrated that suloctidil inhibits calcium influx (17, 18) , perhaps by affecting membrane fluidity (19) . Because of its amphiphilic character, suloctidil has the property of binding readily to cell membranes, especially to the acidic phospholipids (20) .
In this work, the effect of suloctidil on LDL binding, internalization and degradation was investigated. Cholesterol synthesis and esterification have been also shown to be affected by suloctidil.
Materials and Methods
Cell culture MRC5 (human foetal lung) fibroblasts were purchased from Biomerieux France, and maintained in Nunc flasks with Didbecco's medium (Gibco) supplemented with 10% foetal calf serum (Gibco) at 37 °C, in a 5% CO 2 I]LDL degradation, the incubation medium (0.5 ml) was removed before cell washing and 0.25 ml of 500 g/1 trichloroacetic acid was added. The samples were maintained at room temperature for 10 min. The precipitate was centrifuged for 10 min at 4000 g. Ten microlitres of 400 g/ΪΚΙ and 50 μΐ of 300 g/kg H 2 O 2 were then added to 0.5 ml of the supernatant. After mixing, the samples were maintained for 30 min at 4°C, then extracted with 2 ml chloroform, and radioactivity counted on 0.2 ml of the upper phase. Results are calculated in ng LDL per mg of cell protein and then expressed as fraction of control value. Protein was determined by the method of Lowry et al. (23) .
Effect of suloctidil on cholesterol metabolism
Experiments were performed with sodium [l- . Cells were pretreated for 24 h with suloctidil. After evaporation to dryness in a nitrogen stream, oleic acid was resuspended for 15 min at 37 °C in a fatty acid-free human serum albumin solution 0.2 g/1. Radioactive sodium acetate (1.11 GBq/1) or oleic acid (18.5 MBq/1) was then added and a further 4 h incubation performed. Cells were washed three times and lipid analysis performed by thin layer chromatography after direct application of the cell suspension on silica gel plates, using a modification of the method described by Dosado et al. (24) . Neutral lipids were separated by the solvent system hexane/diethylether/acetic acid 70/30/2 (by vol.) and phospholipids by the solvent system chloroform/methanol/acetic acid/H 2 O 50/ 30/8/4 (by vol.). After autoradiography, the radioactive spots were cut out and counted by liquid scintillation. Results are expressed in pmol of precursor incorporated per mg cellular protein.
Results
The effects of suloctidil on LDL binding, uptake and degradation are shown in figure 1 , showing that the three parameters were increased after a 24 h treatment with suloctidil. However, uptake was somewhat more sensitive to suloctidil than binding and degradation. At 10 μιηοΐ/ΐ, suloctidil induced a 1.4, 1.8 and 1.5 fold increase in binding, uptake and degradation, respectively. At concentrations higher than 10 μτηοΐ/ΐ, a cytotoxic effect of suloctidil was observed in our system. Sterol synthesis from sodium acetate and cholesterol esterification with oleic acid were also studied after a 24 h pretreatment with suloctidil. The results in table 1 demonstrate that suloctidil caused a dose-dependent stimulation of sterol synthesis. At 10 μιηοΐ/ΐ, sterol synthesis was about 1.8 fold increased. However, it must be noted that this effect was not specific: fatty acid and triacylglycerol synthesis were also increased in the presence of suloctidil, albeit to a lesser extent. As for cholesterol esterification, the results in table 2 indicate that the incorporation of oleic acid into dbw> lesteryl esters was notably decreased in the presence of suloctidil; at 10 μιτηοΐ/ΐ, cholesterol esterification was about one third ofthat in the controls. This effect appeared to be specific, since the incorporation into triacylglycerols and phospholipids, taken as the internal control, were not affected.
In another set of experiments, oleic acid incorporation into cholesteryl esters was measured in cholesterolladen cells (tab. 3). It can be seen that in the presence of cholesterol 25 g/i in ethanol solution, the incorp oration into cholesteryl esters, which reflects the activity of the enzyme acylcoenzyme A : 'CholesterolOacyl trafisfefase was about 4-fold higher than in non-laden cells. Moreover, the decrease xif cholesterol Cells were pretreated for 24 h with suloctidil in medium supplemented with 10% foetal calf serum for induction of the enzyme acyl Coenzyme A : cholesterol acyl transferase. [1- 
Discussion
Suloctidil induced an increase f LDL binding by cultured human fibroblasts. This increase might be due to modification of either the number of LDL receptors or of the affinity of LDL receptors. Previous work from our laboratories demonstrated that the effect of amphiphilic drugs on LDL binding is rapid (7) and due to an increase in LDL receptor number (10) , probably by unmasking a cryptic pool of unavailable receptors. It is most likely that the amphiphilic drug, suloctidil, exerts its effect on LDL binding by this mechanism.
After binding, LDL receptors are internalized in coated vesicles, which give rise to endosomes (25) . Endosomes then reach the Golgi apparatus (26) and finally the lysosomes, where degradation is achieved. The fact that suloctidil increases LDL uptake and degradation suggests that some of these processes are affected by the drug, either directly after intercalation in the phospholipid bilayer (20) or indirectly by its effect on calcium influx (17, 18) . It is of note that a similar effect on LDL processing was recently described by Stein et al. with another calcium antagonist : verapamil (27) .
A stimulation of sterol synthesis and an inhibition of cholesterol esterification were observed with suloctidil. These results are the reverse of what could be expected if suloctidil only acts through its ability to increase LDL processing. Thus, the effects of suloctidil on cholesterol metabolism are independent of its action on LDL metabolism. Further evidence arises from the fact that for the study of sterol synthesis, suloctidil was introduced in serum-free medium, which thus contained no LDL. It must be noted that the activities of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase and acylcoenzyme A : cholesterol-O-acyl-transferase have been shown to be modulated by the physico-chemical properties of cell membranes, especially by membrane microviscosity (28, 29) . The stimulation of lipid synthesis together with the specific inhibition of cholesterol esterification have also been observed with other amphiphilic drugs such as proprariolol and phenothiazines (10) . However, the calcium-blocking properties of the drug suloctidil might also be involved, since Ranganathan et al. (30) re·-ported that calcium-blocking agents such as verapamil or diltiazem also stimulate sterol synthesis. Thus, the observed effects of suloctidil on LDL processing and cholesterol metabolism might be related to both its amphiphilic characteristics and its calcium^blocking properties.
